Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation

焦点粘着 癌症研究 激酶 细胞生物学 信号转导 生物 医学
作者
Xinhua Song,Hongwei Xu,Pan Wang,Jingxiao Wang,Silvia Affò,Haichuan Wang,Meng Michelle Xu,Bin-yong Liang,Li Che,Wei Qiu,Robert F. Schwabe,Tammy T. Chang,Marion Vogl,Giovanni Mario Pes,Silvia Ribback,Matthias Evert,Xin Chen,Diego Francesco Calvisi
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:75 (4): 888-899 被引量:113
标识
DOI:10.1016/j.jhep.2021.05.018
摘要

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that is upregulated in many tumor types and is a promising target for cancer therapy. Herein, we elucidated the functional role of FAK in intrahepatic cholangiocarcinoma (iCCA) development and progression.Expression levels and activation status of FAK were determined in human iCCA samples. The functional contribution of FAK to Akt/YAP murine iCCA initiation and progression was investigated using conditional Fak knockout mice and constitutive Cre or inducible Cre mice, respectively. The oncogenic potential of FAK was further examined via overexpression of FAK in mice. In vitro cell line studies and in vivo drug treatment were applied to address the therapeutic potential of targeting FAK for iCCA treatment.FAK was ubiquitously upregulated and activated in iCCA lesions. Ablation of FAK strongly delayed Akt/YAP-driven mouse iCCA initiation. FAK overexpression synergized with activated AKT to promote iCCA development and accelerated Akt/Jag1-driven cholangiocarcinogenesis. Mechanistically, FAK was required for YAP(Y357) phosphorylation, supporting the role of FAK as a central YAP regulator in iCCA. Significantly, ablation of FAK after Akt/YAP-dependent iCCA formation strongly suppressed tumor progression in mice. Furthermore, a remarkable iCCA growth reduction was achieved when a FAK inhibitor and palbociclib, a CDK4/6 inhibitor, were administered simultaneously in human iCCA cell lines and Akt/YAP mice.FAK activation contributes to the initiation and progression of iCCA by inducing the YAP proto-oncogene. Targeting FAK, either alone or in combination with anti-CDK4/6 inhibitors, may be an effective strategy for iCCA treatment.We found that the protein FAK (focal adhesion kinase) is upregulated and activated in human and mouse intrahepatic cholangiocarcinoma samples. FAK promotes intrahepatic cholangiocarcinoma development, whereas deletion of FAK strongly suppresses its initiation and progression. Combined FAK and CDK4/6 inhibitor treatment had a strong anti-cancer effect in in vitro and in vivo models. This combination therapy might represent a valuable and novel treatment against human intrahepatic cholangiocarcinoma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Peiqi的应助被雪山飞龙采纳,获得10
刚刚
2秒前
蓝精灵完成签到,获得积分10
4秒前
yuki完成签到 ,获得积分10
4秒前
漾漾的羊完成签到 ,获得积分10
6秒前
dianeil完成签到,获得积分10
14秒前
王不凡完成签到 ,获得积分10
16秒前
LWJ完成签到 ,获得积分10
16秒前
竹舍翁暮雨君完成签到 ,获得积分10
19秒前
机智的孤兰完成签到 ,获得积分10
19秒前
拼搏忆文完成签到,获得积分10
22秒前
康康舞曲完成签到 ,获得积分10
23秒前
XU博士完成签到,获得积分10
24秒前
轻歌水越完成签到 ,获得积分10
25秒前
风趣朝雪完成签到,获得积分10
26秒前
Robin完成签到 ,获得积分10
29秒前
一瓣橘子完成签到,获得积分10
30秒前
kk完成签到,获得积分10
34秒前
Fan完成签到 ,获得积分0
35秒前
蔡勇强完成签到 ,获得积分10
38秒前
bo完成签到 ,获得积分0
39秒前
lpp完成签到 ,获得积分10
40秒前
Heby完成签到 ,获得积分10
40秒前
小山己几完成签到,获得积分10
45秒前
吉吉完成签到,获得积分10
45秒前
望向天空的鱼完成签到 ,获得积分10
46秒前
詹姆斯哈登完成签到,获得积分0
47秒前
高贵的鸿涛完成签到,获得积分10
50秒前
凡凡完成签到,获得积分10
51秒前
三羧酸循环完成签到,获得积分10
51秒前
goy完成签到,获得积分10
52秒前
Alvin完成签到 ,获得积分10
52秒前
一叶知秋完成签到,获得积分10
52秒前
俏皮冰露完成签到,获得积分10
53秒前
戴肉肉完成签到 ,获得积分10
53秒前
yoooooooo完成签到,获得积分10
54秒前
猫猫豆包完成签到 ,获得积分10
54秒前
还在学习完成签到 ,获得积分10
55秒前
悟空完成签到,获得积分10
58秒前
狮山教授发布了新的文献求助10
58秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180053
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808682
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012